Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 11Recruiting 3Terminated 2Withdrawn 1Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 10Neoplasms 1Neoplasm Metastasis 1Liver Metastasis Colon Cancer 1Colonic Neoplasms 1Carcinoma, Neuroendocrine 1

Interventions

Fluorouracil 34Leucovorin 31Oxaliplatin 25Irinotecan 19Capecitabine 13Folfox protocol 11Chemotherapy, Adjuvant 11Cetuximab 11Bevacizumab 9Neoadjuvant Therapy 8XELOX 7Laparoscopy 7Drug Therapy 7Endoscopic Mucosal Resection 5Colonoscopy 5Surgical Procedures, Operative 4Gemcitabine 4Tegafur 3Radiotherapy 3Propofol 3Preoperative Exercise 3Panitumumab 3Fentanyl 3Curcumin 3Colectomy 3Celecoxib 3Aspirin 3raltitrexed 2Surveys and Questionnaires 2Sodium Chloride 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Colonic Neoplasms × IFL protocol × Clear all
NCT04259944 2023-09-28

Post-surgical Liquid Biopsy-guided Treatment of Stage III and High-risk Stage II Colon Cancer Patients: the PEGASUS Trial

IFOM ETS - The AIRC Institute of Molecular Oncology

Phase 2 Unknown
140 enrolled
Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡